Boston Scientific invests US$62.5M in new manufacturing, supply chain facility in Johns Creek, Georgia, creating 340 jobs in next seven years; after buying Georgia-based EndoChoice in 2016, Boston Scientific currently employs about 300 people in Georgia

Sample article from our Tissue & Hygiene

ATLANTA, Georgia , June 29, 2022 (press release) –

Governor Brian P. Kemp today announced that Boston Scientific, a leading manufacturer of medical devices used in interventional medical specialties, will construct a new manufacturing and supply chain facility in Johns Creek. The $62.5 million investment is expected to bring roughly 340 new jobs to Fulton County over the next seven years.

"As home to some of the leading universities and technical colleges in the country, Georgia produces top talent for growing fields like the Life Sciences industry," said Governor Kemp. "Boston Scientific will find well-educated, well-trained, and hardworking Georgians who are eager to support the company’s life-changing work to fill these new positions. I look forward to seeing the impact of this expansion here in Georgia and far beyond as they keep the Peach State on the cutting edge of medical science."

Headquartered in Massachusetts, Boston Scientific designs, develops, and manufactures a wide range of medical devices and therapies used in less-invasive procedures across a range of medical specialties. Its solutions and technologies are used by healthcare providers in specialties like endoscopy, cardiology, peripheral interventions, oncology, urology, and neurology. Its more than 17,000 products are used to treat approximately 30 million patients around the world each year.

"As we expand our presence in Georgia, we remain grateful to all of our local employees whose work is already making a difference for healthcare providers and patients around the world," said Brad Sorenson, Executive Vice President, Global Operations at Boston Scientific. "Our new site in Johns Creek will enable continued growth as we fulfill our mission to transform lives."

In 2016, Boston Scientific purchased Georgia-based EndoChoice. Boston Scientific employs approximately 300 individuals in Georgia and more than 41,000 individuals globally. Its new facility will be located at 11350 Johns Creek Parkway in Johns Creek.

"We are thrilled that Boston Scientific has chosen Johns Creek for their state-of-the-art facility," said Johns Creek Mayor John Bradberry. "By locating in our Town Center, Boston Scientific underscores Johns Creek as a leading destination for healthcare innovation and wellness."

"Today’s announcement is a game changer for Fulton County, adding such a world class brand like Boston Scientific to our life science ecosystem," said Marty Turpeau, Chairman of the Development Authority of Fulton County. "We work hard as an Authority to strategically use our tools to help our cities grow through new investment and job creation, and today is the result of that work."

"We could not be more thrilled with the decision by Boston Scientific to significantly expand their operations with a new facility in Johns Creek," said Metro Atlanta Chamber President and CEO Katie Kirkpatrick. "Metro Atlanta is rich in assets to support the life sciences industry, including our medical schools, our universities, our large cluster of life science businesses, our highly educated and skilled workforce and more. The region is experiencing growing momentum in the life sciences industry, and we look forward to supporting Boston Scientific with their expansion plans."

Director of Life Sciences EJane Caraway represented the Georgia Department of Economic Development’s (GDEcD) Global Commerce team on this competitive project in partnership with the City of Johns Creek, the Fulton County Development Authority, Metro Atlanta Chamber, Georgia Power, and Georgia Quick Start.

"We welcome the expansion of a highly respected company like Boston Scientific, which is an ideal addition to the robust and growing life sciences ecosystem in Georgia," said GDEcD Commissioner Pat Wilson. "Collaborative relationships between the state’s universities, technical college systems, and companies inspire innovation, and we are excited that Boston Scientific recognizes this opportunity. Thank you to our partners in the City of Johns Creek and Fulton County for their support in bringing this important project home."

There are more than 2,200 clinical trials recruiting or underway in Georgia. From 2014 through 2017, there were 547 patents awarded to applicants from Georgia for drugs and pharmaceuticals. In 2021, Georgia exported $3.2 billion in immunological products and $1.9 billion in medical devices and pharmaceuticals.

Contact:
Katie Byrd - Director of Communications

Office of Governor Brian P. Kemp

katie.byrd@georgia.gov

Andrew Isenhour - Deputy Director of Communications

Office of Governor Brian P. Kemp

andrew.isenhour@georgia.gov

Marie Gordon - Director of Communications

Georgia Department of Economic Development

mgordon@georgia.org

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Dan Rivard
Dan Rivard
- VP Market Development -

We offer built-to-order tissue & hygiene coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.